Brentford, TW8 9GS,
United Kingdom
GSK United Kingdom Technographics
Discover the latest software purchases and digital transformation initiatives being undertaken by GSK United Kingdom and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 1400 GSK United Kingdom employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that GSK United Kingdom has purchased the following applications: Aspen Process Pulse for Asset Performance Management in 2021, Amazon Elastic Load Balancing (ELB) for Content Delivery Network in 2021 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems GSK United Kingdom is running and its propensity to invest more and deepen its relationship with AspenTech , Amazon Web Services (AWS) or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing GSK United Kingdom revenues, which have grown to $804.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for GSK United Kingdom intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
ERP Services and Operations
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| AspenTech | Legacy | Aspen Process Pulse | Asset Performance Management | ERP Services and Operations | n/a | 2021 | 2021 |
In 2021, GSK United Kingdom implemented Aspen Process Pulse together with Aspen Unscrambler to monitor bioreactor pH and detect probe faults in a manufacturing/quality (process/PAT) deployment. The implementation targeted bioprocess monitoring within pharmaceutical manufacturing sites in the United Kingdom, focusing on real time process analytical technology capabilities to protect batch quality.
Aspen Process Pulse was configured to run continuous process monitoring and fault detection workflows, applying PAT analytics for pH sensor validation and early anomaly identification. Configuration emphasized probe health diagnostics and automated flagging of out‑of‑range signals, enabling operational teams to intervene before batch compromise.
The deployment integrated Aspen Process Pulse with Aspen Unscrambler for complementary multivariate analysis and pattern recognition, consolidating sensor telemetry and advanced analytics for bioreactor pH control. Operational coverage spanned manufacturing and quality functions, with system outputs feeding shift operations and quality review processes to support batch disposition decisions.
Governance centered on process monitoring and fault remediation workflows, with defined escalation for probe faults and batch hold decisions. The implementation delivered early fault detection and reduced wasted batches, preventing an estimated $5 million loss of biopharma drug substance.
|
IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Amazon Web Services (AWS) | Legacy | Amazon Elastic Load Balancing (ELB) | Content Delivery Network | IaaS | n/a | 2021 | 2021 |
|
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||